Earnings Ahead

HALO - Halozyme Therapeutics, Inc.

34.2 -0.64 -1.84

Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc.

About

Profile


Headquarters

San Diego, California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

HALO



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Halozyme Therapeutics Non-GAAP EPS of $0.82 misses by $0.01, revenue of $230.04M misses by $1.1M
  • Halozyme Therapeutics Q4 2023 Earnings Preview
  • J&J seeks expanded FDA approval of Darzalex Faspro for multiple myeloma
  • EU okays Takeda's Hyqvia co-formulated with Halozyme's Enhanze
  • Lipocine licenses Tlando testosterone therapy to Verity Pharma
  • Regeneron’s high-dose Eylea, argenx’s Vyvgart injectable among latest approvals in Japan
  • Halozyme’s early 2023 results indicate a mixed performance
  • Halozyme gains as U.S. and EU clear Enhanze-based products
  • Top overweight stocks with high free cash flow and EPS growth - MS
  • JNJ multiple myeloma therapy outperforms standard of care by 58%
  • argenx slips as autoimmune disorder therapy fails in pivotal trial
  • Teva gains U.S. approval for generic version of osteoporosis injection
  • Argenx Vyvgart injectable granted EU nod for myasthenia gravis
  • Halozyme Therapeutics Non-GAAP EPS of $0.75 beats by $0.04, revenue of $216M in-line
  • Halozyme, Acumen enter collaboration for Alzheimer's drug candidate
  • Earnings week ahead: Disney, AMC, Plug Power, Lucid, Realty Income and more
  • Halozyme Therapeutics Q3 2023 Earnings Preview
  • Bristol Myers succeeds in Phase 3 trial for subcutaneous Opdivo
  • Roche granted U.K. approval for subcutaneous Tecentriq
  • Halozyme Therapeutics Non-GAAP EPS of $0.74 beats by $0.10, revenue of $221.04M beats by $21.09M
PEERS
/XLV

XLV

Date Price Open High Low Vol Change
Dec 2 66.54 68
68.6
66.38
1.9M -2.29%
Dec 1 68.1 71.97
72
68.01
2.3M -4.62%
Nov 28 71.4 72.54
72.78
70.49
1.1M -1.73%
Nov 26 72.66 72.82
74.25
72.17
1.3M -0.22%
Nov 25 72.82 74.15
74.22
72.27
2.4M -1.59%
 
Nov 24 74 70.43
74.01
69.9
5.7M 5.20%
Nov 21 70.34 68.97
70.76
68.09
2.2M 1.99%
Nov 20 68.97 70.58
70.81
68.73
1.0M -1.82%
Nov 19 70.25 70.53
70.53
68.96
1.7M 0.21%
Nov 18 70.1 70.08
71.08
69.69
1.3M -0.65%
Nov 17 70.56 70.51
72.71
70.25
2.0M 0.76%
Nov 14 70.03 70.55
71.54
69.72
1.7M -1.63%
Nov 13 71.19 70.31
72.66
70.22
3.5M 0.79%
Nov 12 70.63 70.4
71.8
69.54
1.9M 0.71%
Nov 11 70.13 67.96
70.23
67.39
1.9M 3.12%
Nov 10 68.01 68.48
69.39
67.98
2.5M -0.34%
Nov 7 68.24 69.02
70
67.52
11.7M -0.22%
Nov 6 68.39 68.3
70.5
67.39
2.3M 0.13%
Nov 5 68.3 68.31
70.49
67.8
1.5M 0.37%
Nov 4 68.05 67.64
69.93
65
2.4M 2.79%
Nov 3 66.2 65.98
66.38
64.72
2.8M 1.55%
Oct 31 65.19 64.1
65.49
63.84
1.4M 0.87%
Oct 30 64.63 65.51
66.24
63.94
1.8M -0.97%
Oct 29 65.26 65.74
66.97
64.95
1.5M -0.21%
Oct 28 65.4 65.65
66.25
64.55
959K -0.68%
Oct 27 65.85 66.8
66.99
65.56
1.3M -0.45%
Oct 24 66.15 66.99
67.28
66.11
994K -1.11%
Oct 23 66.89 65.99
66.98
65.63
1.4M 1.70%
Oct 22 65.77 67.03
67.36
65.76
1.4M -1.66%
Oct 21 66.88 66.53
67.03
65.96
1.7M 0.62%
Oct 20 66.47 67.07
67.26
65.14
1.4M -0.84%
Oct 17 67.03 66.97
67.54
66.18
2.2M 0.22%
Oct 16 66.88 66.33
67.31
65.65
1.7M 0.78%
Oct 15 66.36 67.42
67.62
65.64
2.1M -0.44%
Oct 14 66.65 64.8
68
64.8
2.6M 2.02%
Oct 13 65.33 64.26
65.75
64.1
1.7M 1.92%
Oct 10 64.1 65.54
65.6
63.78
1.5M -1.55%
Oct 9 65.11 65.2
65.62
64.19
1.7M -0.14%
Oct 8 65.2 66.03
66.48
64.62
1.9M -1.24%
Oct 7 66.02 66.6
66.92
65.05
2.7M -1.42%
Oct 6 66.97 68.58
68.83
66.64
2.6M -2.91%
Oct 3 68.98 71.75
71.84
68.04
2.7M -3.78%
Oct 2 71.69 74.98
75.5
69.7
2.9M -4.34%
Oct 1 74.94 75.2
76.3
74.3
4.4M 2.18%
Sep 30 73.34 73.96
74.93
73.06
1.8M 0.07%
Sep 29 73.29 73.75
74.04
73.2
1.9M -0.62%
Sep 26 73.75 74.72
75.25
73.18
2.2M -0.3%
Sep 25 73.97 75.47
75.59
73.61
2.4M -2.21%
Sep 24 75.64 77.93
78.32
75.39
2.2M -2.49%
Sep 23 77.57 78.79
79.5
77.46
1.8M -0.91%
Sep 22 78.28 78.12
79.31
77.05
1.6M 0.60%
Sep 19 77.81 76.69
77.95
76.17
6.3M 1.47%
Sep 18 76.68 75.77
76.98
75.31
1.7M 1.15%
Sep 17 75.81 75.7
76.61
75.19
1.5M -0.05%
Sep 16 75.85 76.41
76.41
75.33
1.1M -0.63%
Sep 15 76.33 77.18
77.18
75.25
1.3M -0.74%
Sep 12 76.9 77.04
77.6
76.51
1.1M -0.81%
Sep 11 77.53 76
77.58
75.68
2.2M 2.28%
Sep 10 75.8 76.3
76.34
74.51
1.1M -0.35%
Sep 9 76.07 76
76.1
74.85
1.4M 0%